The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease

Sci Rep. 2020 Oct 29;10(1):18648. doi: 10.1038/s41598-020-73482-6.

Abstract

Very early onset inflammatory bowel disease (VEOIBD) denotes children with onset of IBD before six years of age. A number of monogenic disorders are associated with VEOIBD including tetratricopeptide repeat domain 7A (TTC7A) deficiency. TTC7A-deficiency is characterized by apoptotic colitis in milder cases with severe intestinal atresia and immunodeficiency in cases with complete loss of protein. We used whole exome sequencing in a VEOIBD patient presenting with colitis characterized by colonic apoptosis and no identified known VEOIBD variants, to identify compound heterozygous deleterious variants in the Ubiquitin protein ligase E3 component N-recognin 5 (UBR5) gene. Functional studies demonstrated that UBR5 co-immunoprecipitates with the TTC7A and the UBR5 variants had reduced interaction between UBR5 and TTC7A. Together this implicates UBR5 in regulating TTC7A signaling in VEOIBD patients with apoptotic colitis.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Amino Acid Sequence
  • Child, Preschool
  • Humans
  • Inflammatory Bowel Diseases / metabolism*
  • Male
  • Protein Binding
  • Proteins / metabolism*
  • Sequence Homology, Amino Acid
  • Signal Transduction
  • Ubiquitin-Protein Ligases / metabolism*

Substances

  • Proteins
  • TTC7A protein, human
  • UBR5 protein, human
  • Ubiquitin-Protein Ligases